sales@scalarmarketresearch.com  |   +1-800-213-5170  (U.S./ Canada Toll-free)  |  REGISTER |  SIGN IN

Home >> Reports >> neurostimulation market

report

Neurostimulation Market, by Therapies (Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation and Vagus Nerve Stimulation) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022

HC181 November 2016 100+ FREE 10% CUSTOMIZATION

The objective of this report is to describe the market trends and revenue forecasts for the neurostimulation market for the next five years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.

The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the neurostimulation market. The scope of this report covers the neurostimulation market by its major segments, which include the therapies and the major geographic regions.

KEY BENEFITS OF THE REPORT

  • In-depth analysis of the market ecosystem and its impact on the revenue growth
  • Meticulous understanding of the key new market opportunities in individual geographic regions/countries
  • Detailed analysis of the significant sustainability strategies adopted by the major players in this market

KEY PREMIUM INDUSTRY INSIGHTS

  • Advancements in neurostimulation technology, huge investments in research & development of neurostimulation, increasing FDA approvals for clinical trials, and the rising incidences of neuropathic pain are the key drivers for the neurostimulation market during the forecast period.
  • Rising number of geriatric population and the increasing age-related disorders such as Parkinson’s, epilepsy, sleep disorders, and depression will further boost the neurostimulation market.
  • Additionally, adaptation of neurostimulation devices in the emerging markets such as in China, Mexico, and India, as well as the European nations will fuel the market growth further.
  • The FDA approvals and rising applications of neurostimulation will also drive the market growth in the near future.
  • However, the unclear reimbursement policies, high costs, and unavailability of reliable measuring systems are the major restraining factors for the neurostimulation market.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s neurostimulation market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the neurostimulation market by the following segments:

  • Neurostimulation Market, by Therapies
    • Spinal Cord Stimulation
    • Deep Brain Stimulation
    • Sacral Nerve Stimulation
    • Vagus Nerve Stimulation

KEY MARKET PLAYERS

Key players in the neurostimulation market include:

Boston Scientific Corporation

  • Medtronic
  • Synapse
  • St. Jude Medical, Inc.
  • Nevro Corp
  • Neuropace, Inc.
  • Neurosigma, Inc.
  • Neuronetics
  • BioControl Medical
  • Cyberonics, Inc.

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

  • NORTH AMERICA
    • U.S.
    • Rest of North America
  • EUROPE
    • France
    • Germany
    • U.K
    • Rest of Europe
  • ASIA-PACIFIC
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • REST OF THE WORLD
    • Latin America
    • Middle East & Africa

Neurostimulation Market

TRENDING RELATED REPORT

Stem Cell Therapy Market, by Treatments (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy), Applications (Oncology, Eye Diseases, Central Nervous System Diseases, Musculoskeletal Diseases, Wound & Injuries, Metabolic Disorders, Cardiovascular Disorders, Immune System Disorders), End-users (Hospitals, Ambulatory Surgical Centers) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022


  1. MARKET OVERVIEW
    1. Market Definition
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
    2. Pricing Analysis
    3. Regulatory Analysis
    4. Reimbursement Landscape
  5. NEUROSTIMULATION MARKET, BY THERAPIES
    1. Segment Share
    2. By Therapies
      1. Spinal Cord Stimulation
      2. Deep Brain Stimulation
      3. Sacral Nerve Stimulation
      4. Vagus Nerve Stimulation
  6. NEUROSTIMULATION MARKET, BY GEOGRAPHY
    1. North America
      1. By Country
        1. U.S.
        2. Rest of North America
      2. By Therapies
    2. Europe
      1. By Country
        1. France
        2. Germany
        3. U.K.
        4. Rest of Europe
      2. By Therapies
    3. Asia-Pacific
      1. By Country
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Therapies
    4. Rest of the World (ROW)
      1. By Country
        1. Latin America
        2. Middle East & Africa
      2. By Therapies
  7. COMPETITIVE LANDSCAPE
    1. Market Share Analysis
    2. Key Innovator Companies
  8. KEY MARKET PLAYERS
    1. Boston Scientific Corporation
      1. Overview
      2. Key Strategies
      3. Recent Developments
    2. Medtronic
      1. Overview
      2. Key Strategies
      3. Recent Developments
    3. Synapse Biomedical, Inc
      1. Overview
      2. Key Strategies
      3. Recent Developments
    4. St. Jude Medical, Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    5.  Nevro Corp
      1. Overview
      2. Key Strategies
      3. Recent Developments
    6. Neuropace, Inc
      1. Overview
      2. Key Strategies
      3. Recent Developments
    7.  Neurosigma, Inc
      1. Overview
      2. Key Strategies
      3. Recent Developments
    8.  Neuronetics
      1. Overview
      2. Key Strategies
      3. Recent Developments
    9. BioControl Medical
      1. Overview
      2. Key Strategies
      3. Recent Developments
    10. Cyberonics, Inc
      1. Overview
      2. Key Strategies
      3. Recent Developments
  9. SCALAR 360 DEGREE MARKET PERSPECTIVE
  10. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170
EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

  • Unparalleled Expertise

    Our industry experts hold inimitable know-how across wide range of industry verticals

  • Assured Quality

    We deliver high-quality, real-time and data-driven industry insights to our clients

  • 24x7 Analyst Support

    We offer pre-purchase and post-purchase support from our industry experts

  • Privacy & Security

    All your personal information and confidential details are safe and secure with us